The largest database of trusted experimental protocols

Envision flex substrate buffer

Manufactured by Agilent Technologies
Sourced in Denmark

The Envision Flex Substrate Buffer is a laboratory product designed to facilitate the preparation of samples for analysis using various analytical techniques. It is a pre-formulated solution that serves as a buffer, providing the appropriate pH and ionic conditions for the sample matrix. The core function of this product is to help maintain the integrity and stability of the sample during the analysis process.

Automatically generated - may contain errors

10 protocols using envision flex substrate buffer

1

Immunohistochemistry of Tau and Myc in Mouse Brain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were immersion fixed in 4% PFA rather than perfused because of their small size, brains embedded in paraffin and 7 μm sections obtained as described (Deters et al., 2008 (link)). For antigen retrieval, the sections were microwaved in AR buffer (Dako Envision Flex Target Retrieval Solution low pH #K8005) for 15 min on low power before the buffer started to boil. The sections were then left to cool for 1h in the AR buffer at RT. Blocking was done in 20% FBS, 1% BSA in TBST for 1h at RT. Primary antibodies were used over night at 4°C and secondary antibodies for 1.5h at RT. Primary antibodies were Myc-Tag rabbit mAb (Cell Signaling Technologies, #71D10, used at 1:100) and anti-Human PHF-Tau Monoclonal Antibody AT8 (Thermo Fisher, MN1020, used at 1:400). Secondary antibodies were polyclonal goat anti-rabbit IgG biotinylated (Dako, #E0432, used at 1:500) and polyclonal rabbit anti-mouse IgG biotinylated (Dako, #E0413, used at 1:500). The VectaStain Elite ABC Kit #PK6102 was used and Envision Flex DAB chromogen (Dako, #DM827) and Envision Flex Substrate Buffer (Dako, # DM823) for DAB development. Haematoxylin was used for counter-staining.
+ Open protocol
+ Expand
2

Detailed Immunohistochemistry and Immunofluorescence Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor samples were fixed in 4% paraformaldehyde for 24 h and then embedded in paraffin. Paraffin blocks were cut into 5 μm sections and used for hematoxylin and eosin (HE), immunohistochemistry (IHC), or Immunofluorescence (IF) staining.
For IHC, slides were deparaffinized through xylenes and graded ethanol, then performed antigen retrieval using citrate buffer at pH 6.0. After washing, slides were blocked with 0.3% H2O2 and 5% normal goat serum sequentially, followed by staining with primary antibody at 4 °C overnight. Next, slides were incubated with EnVision FLEX/HRP (SM802, DAKO, Glostrup, Denmark) at RT for 20 min, followed by using EnVison FLEX DAB + CHROMOGEM and EnVision FLEX substrate buffer (DM827 and SM803, DAKO, Glostrup, Denmark) to visualize staining signals under light microscopy, finally counterstained using hematoxylin solution. Finally, stained slides were scanned using Ocus (Grundium, Tampere, Finland) and analyzed with Qupath software.
For IF, procedures before primary antibodies incubation were the same as IHC, except for H2O2 blocking. First, slides were incubated with primary antibody at 4 °C overnight, followed by secondary antibodies. Finally, the slides were counterstained with DAPI in an antifade solution (DAPI Fluoromount-G, 0100-20, SouthernBiotech) and then mounted. Images were taken with Leica SP8 confocal microscope.
+ Open protocol
+ Expand
3

Immune Response to OxPVA/Chs Scaffold Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The host immune response towards OxPVA/Chs scaffolds implantation was characterized by the immunolocalization of lymphocyte T (CD3+) and monocyte/macrophage (F4/80+) infiltrates at the graft boundaries. Formalin-fixed and paraffin-embedded sections (3 µm thickness) were dewaxed and rehydrated as described in Section 4.4.2; hence, immunohistochemical reactions were performed by Dako Autostainer/Autostainer Plus (Dako, Milan, Italy) with the following primary antibodies diluted in PBS: anti-CD3 (polyclonal rabbit anti-CD3, A0452, Dako) (1:500) and anti-F4/80 (polyclonal rabbit anti-F4/80 (M-17)-R, sc-26643-R, Santa Cruz Biotechnology) (1:1000) to label lymphocytes and monocytes/macrophages, respectively. The binding between the primary antibody and specific antigens was then revealed using a labelled polymer (EnVision™ FLEX-HRP; Dako) and 3,3′-diaminobenzidine (EnVision™ FLEX Substrate buffer + DAB + Chromogen; Dako). Meanwhile, negative controls were developed without incubation with primary antibodies.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of Collagen Types

Check if the same lab product or an alternative is used in the 5 most similar protocols
After culture, matrices were embedded in HistoGel, fixed in 4% paraformaldehyde and paraffin wax-embedded for sectioning and staining for human collagen type IV (mouse anti-human collagen IV monoclonal antibody 2150–0121, Bio-Rad, CA, USA) and human collagen type I/III (rabbit anti-human collagen I/III polyclonal antibody 2150–2210, Bio-Rad, CA, USA). After automated antigen retrieval processing (PT Link Machine, DAKO, Denmark), sections were washed three times for five minutes in wash buffer (EnVision Flex Wash Buffer, DAKO, Denmark), blocked for ten minutes in blocking reagent (EnVision FLEX peroxidase-blocking reagent, DAKO, Denmark), washed a further three times, incubated with primary antibody diluted in substrate buffer (EnVision Flex Substrate Buffer, DAKO, Denmark) for one hour at room temperature, washed three times, and incubated with secondary antibody (EnVision FLEX/HRP, DAKO, Denmark) for 30 minutes at room temperature. After three washes, 3,3-diaminobenzidine tetrahydrochloride (DAB) solution (EnVision FLEX DAB, DAKO, Denmark) was added with H&E counterstain. Acellular matrix (consisting of rat type I collagen) was used as a negative control, and normal human kidney was used as a positive control.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of CEA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunohistochemical analysis the histological slides were pretreated for 15 minutes with Dako PTLink with EnVision™ FLEX Target Retrieval Solution, High pH (Dako DM827). Thereafter followed a five minutes treatment with EnVision™ FLEX Peroxidase-Blocking Reagent (Dako SM801) and incubation with ready-to-use primary antibody (Carcinoembryonic Antigen (CEA) Clone II-7 (Dako IR622) for 20 minutes. Visualization was done with HRP-conjugated secondary antibody and DAB chromogen according to the manufacturer's instructions (EnVision™ FLEX /HRP (Dako SM802) and EnVision™ FLEX DAB+ Chromogen (Dako DM827) 1/51 in EnVision™ FLEX Substrate Buffer (Dako SM803)). Sections were counterstained with hemalaun for one minute, dehydrated in an ascending alcohol concentration and covered with Xylol and Coverslipping Film (Tissue-TekR 4770).
CEA expression was quantified by expression intensity (0 to 3) and percentage of CEA-positive tumor cells in vision fields of 200 fold magnifications by two experienced pathologists, blinded for patient data and clinical outcome. For semi-quantitative analyses, CEA expression intensity and expression percentage were multiplied and normalized according to the overall mean.
+ Open protocol
+ Expand
6

Immunohistochemical Staining of FFPE Tumor Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serial sections were cut from the selected FFPE tumor blocks (N = 129) and mounted on FLEX IHC Microscope Slides (K8020, DAKO, Glostrup, Denmark). The pretreatment processes were performed using PT Link (DAKO). Heat-induced epitope retrieval was achieved with Envision Target Retrieval Solution (DAKO) at pH 9 and 97 °C for 20 min.
Staining was performed using a DAKO Autostainer Link 48 (DAKO).
Endogenous peroxidase activity was blocked by Envision FLEX Peroxidase-Blocking Reagent (DAKO). The primary antibodies were mouse monoclonal anti-CD3 (code M7254, DAKO) diluted 1:600, and anti-CD8 (code M7103, DAKO) diluted 1:300. The primary antibodies were diluted with Envision Flex antibody diluent (code S2022 DAKO).
Primary antibodies were incubated for 30 min at room temperature, and for amplification Envision Flex + Mouse(Linker) (DAKO) was used for 20 min. Bound antibodies were detected using Envision FLEX/HRP (DAKO) and visualized by Envision FLEX DAB (DAKO) and chromogene diluted in Envision Flex Substrate Buffer (DAKO). To enhance the immunohistochemical stains, the sections were incubated in 0.5% CuSO4 in TBS buffer pH 7.6 for 10 min. Meyer’s hematoxylin (Merck, Damstadt, Germany) was used as counterstain, and finally, the histological slides were coverslipped with Tissue-Tek PERTEX (Histolab Products AB, Göteborg, Sweden).
+ Open protocol
+ Expand
7

Immunohistochemical Staining of Cytokeratin AE1/AE3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serial sections were cut from the selected tumour blocks (N = 129) and mounted on FLEX IHC Microscope Slides (K8020, Agilent DAKO products, Glostrup, Denmark). The pretreatment processes were performed using PT Link (DAKO). Heat-induced epitope retrieval was achieved with Envision Target Retrieval Solution (DAKO) at pH 9 and 97 °C for 20 min. Staining was performed using a DAKO Autostainer Link 48 (DAKO). Endogenous peroxidase activity was blocked by Envision FLEX Peroxidase-Blocking Reagent (DAKO). The primary antibody was mouse monoclonal cytokeratin AE1/AE3 (code M3515, DAKO) diluted 1:250 with Envision Flex antibody diluent (code S2022 DAKO). Primary antibody was incubated for 30 min. at room temperature, and for amplification Envision Flex+ Mouse (Linker) (DAKO) was used for 20 min. Bound antibodies were detected by Envision FLEX/HRP (DAKO) and visualised by Envision FLEX DAB (DAKO) with chromogen diluted in Envision Flex Substrate Buffer (DAKO). Meyer’s hematoxylin (Merck, Darmstadt, Germany) was used as counterstain and finally, the histological slides were cover slipped with Tissue-Tek PERTEX (Histolab Products AB, Göteborg, Sweden).
+ Open protocol
+ Expand
8

Immunostaining of CD1a-Positive Structures

Check if the same lab product or an alternative is used in the 5 most similar protocols
After de-paraffinization, 5 μm thick sections were immunostained to visualize CD1a-positive structures using Dako Autostainer/Autostainer Plus (Dako, Milan, Italy) and CD1a antibodies (M3571 anti-human CD1a Dako) diluted 1:100 in EnVision buffer. Each section was incubated with peroxidase-blocking serum (EnVision FLEX Peroxidase-Blocking Reagent, Dako) for 5 minutes to quench non-specific binding and then for 30 minutes with the primary antibody. After this, sections were incubated with a labeled polymer (EnVision FLEX /HRP, Dako) for 20 minutes and 3,3’-diaminobenzidine (EnVision FLEX Substrate buffer, + DAB + Chromogen; Dako) to label positive primary antibody binding. All the sections were finally counterstained with Hematoxylin (EnVision FLEX Hematoxylin, Dako) for 5 minutes to reveal the presence of nuclei, then dehydrated with an increasing scale of alcohol solutions (70%, 95%, 99%), cleared with xylene and mounted. These steps were performed at room temperature.[16] (link)
+ Open protocol
+ Expand
9

Survivin and Mucin-1 Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antigen expression of Survivin and Mucin-1 was assessed on archived FFPE blocks of tumor biopsies taken from metastatic lesions. Mucin-1 staining was performed according to a protocol described previously (17 (link)). For Survivin, the procedure was similar. First, 4-μm thickness sections were cut, and slides were deparaffinized and rehydrated prior to antigen retrieval by boiling in EnVision™ FLEX target retrieval solution (pH 9, K8004, Dako) for 10 minutes. Subsequently, endogenous peroxidase was blocked using 3% hydrogen peroxidase (76,051,800.1000, EMD Millipore) in PBS (4391.9010, Klinipath) for 10 minutes. Incubation was performed with a primary anti-Survivin antibody (D8, sc-17779, Santa Cruz Biotechnology, TX, USA, dilution) for 1 hour at room temperature. EnVision™ FLEX Wash Buffer (DM831, Dako) was used to wash between steps. Afterwards, slides were incubated with the secondary antibody BrightVision poly-HRP-anti-Ms/Rb/Rt IgG (DPVO999HRP, ImmunoLogic) at room temperature for 30 min. Finally, incubation with EnVision™ FLEX DAB Buffered Substrate and EnVision™ FLEX Substrate Buffer (K5207 and SM803; DAKO) was done for 10 min at room temperature prior to dehydration, counterstaining with hematoxylin and finally enclosing with Quick-D mounting medium (7281, Klinipath). Finally, a pathologist evaluated antigen expression as either positive or negative.
+ Open protocol
+ Expand
10

Immunohistochemical Analysis of RIG-I and MEX3A

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues used for immunohistochemical staining were fixed in formalin and paraffin-embedded (FFPE). FFPE slides were incubated with monoclonal antibodies against RIG-I or MEX3A (1:100, overnight, at 4 °C). The day after, the slides were incubated for 20 min, with secondary antibodies coupled with peroxidase (Dako). Bound peroxidase was detected by diaminobenzidine (DAB) solution (ScyTek Laboratories, Logan, UT, USA) and EnVision FLEX Substrate buffer containing peroxide (Dako). Cell quantification was performed on collected sections, using the imaging software NIS-Elements BR 4.00.05 (Nikon Instruments Europe B.V., Florence, Italy). Images were captured by HistoFAXS software (TissueGnostics GmbH, Vienna, Austria), at 20× magnification.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!